Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

lilly france, france - fluoxetine - capsule, hard - 20 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

eli lilly (s.a.) (pty) ltd - capsules - see ingredients - each capsule contains fluoxetine hydrochloride equivalent to fluoxetine 20 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

eli lilly (sa) (pty) ltd - capsule - each capsule contains fluoxetine hydrochloride equivalent to fluoxetine 30 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

eli lilly (sa) (pty) ltd - tablet - each tablet contains fluoxetine hydrochloride 22,37 mg equivalent to 20 mg fluoxetine

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

30's plastic bottle -

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

pharmatrade united states of america - 30's plastic bottle - capsule - 20mg/capsule - central nervous system-antidepressants

Malta - English - Medicines Authority

neofarma pharmaceuticals limited 42-46, mill street, qormi, qrm 3105, malta - fluoxetine hydrochloride - orodispersible tablet - fluoxetine hydrochloride 20 mg - psychoanaleptics

Namibia - English - Namibia Medicines Regulatory Council

eli lily - fluoxetine hydrochloride - capsule - each capsule contains fluoxetine hydrochloride equivalent to 20mg fluoxetine

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

lilly france, france - fluoxetine - capsule, hard - 20 mg

United States - English - NLM (National Library of Medicine)

edgemont pharmaceuticals, llc - fluoxetine hydrochloride (unii: i9w7n6b1kj) (fluoxetine - unii:01k63sup8d) - fluoxetine 60 mg - fluoxetine is indicated for the treatment of: the use of maois intended to treat psychiatric disorders with fluoxetine or within 5 weeks of stopping treatment with fluoxetine is contraindicated because of an increased risk of serotonin syndrome. the use of fluoxetine within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated [see dosage and administration (2.6) and warnings and precautions (5.2)] . starting fluoxetine in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome [see dosage and administration ( 2.7 ) and warnings and precautions (5.2 )] . the use of fluoxetine is contraindicated with the following: pimozide and thioridazine prolong the qt interval. fluoxetine can increase the levels of pimozide and thioridazine through inhibition of cyp2d6. fluoxetine can also prolong the qt interval. pregnancy category c —fluoxetine should be used during pregnancy